carbidopa 25 MG / levodopa 250 MG Oral Tablet
carbidopa
RxCUI: 197445
What the CMS Formulary Data Shows for carbidopa 25 MG / levodopa 250 MG Oral Tablet
Per the CMS 2026 Part D formulary file, carbidopa 25 MG / levodopa 250 MG Oral Tablet (RxNorm concept RXCUI 197445, generic name carbidopa) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 1.7.
Real-world access to carbidopa 25 MG / levodopa 250 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 4,842 Part D beneficiaries filled carbidopa 25 MG / levodopa 250 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $8,630,589 and an average per-beneficiary annual cost of $1,782.44. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry carbidopa 25 MG / levodopa 250 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 3
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 4,842
- Total spending
- $8,630,589
- Avg per beneficiary
- $1,782.44
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering carbidopa 25 MG / levodopa 250 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is carbidopa 25 MG / levodopa 250 MG Oral Tablet covered by Medicare Part D?
Yes, carbidopa 25 MG / levodopa 250 MG Oral Tablet is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is carbidopa 25 MG / levodopa 250 MG Oral Tablet on Medicare Part D plans?
carbidopa 25 MG / levodopa 250 MG Oral Tablet averages Tier 1.7 across Part D plans, ranging from Tier 1 to Tier 3.
Does carbidopa 25 MG / levodopa 250 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for carbidopa 25 MG / levodopa 250 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on carbidopa 25 MG / levodopa 250 MG Oral Tablet?
In 2023, total Medicare Part D spending on carbidopa 25 MG / levodopa 250 MG Oral Tablet was $8,630,589, covering 4,842 beneficiaries. The average spend per beneficiary was $1,782.44.
Read our methodology - how this data is sourced, computed, and verified.